Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune check-point inhibitors

被引：0
|
作者：
Looman, E. L. [1 ,2 ,3 ]
Cheng, P. F. [1 ,4 ]
Lai-Kwon, J. [5 ]
Morgan, L. [1 ]
Wakkee, M. [3 ]
Dummer, R. [1 ,4 ]
Dimitriou, F. [1 ,4 ]
机构：
[1] Univ Hosp Zurich, Dermatol, Zurich, Switzerland
[2] Univ Hosp Zurich, Radiat Oncol, Zurich, Switzerland
[3] Erasmus MC, Dermatol, Rotterdam, Netherlands
[4] Univ Zurich, Fac Med, Zurich, Switzerland
[5] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
182
引用
收藏
页码：26S / 26S
页数：1
相关论文
共 50 条
  • [1] Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors
    Looman, E. L.
    Cheng, P. F.
    Lai-Kwon, J.
    Morgan, L.
    Wakkee, M.
    Dummer, R.
    Dimitriou, F.
    CANCER MEDICINE, 2023, 12 (11): : 12861 - 12873
  • [2] Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)
    Dimitriou, F.
    Cheng, P.
    Saltari, A.
    Staeger, R.
    Tastanova, A.
    Levesque, M.
    Long, G.
    Becher, B.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S275 - S275
  • [3] Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors
    Miyake, Makito
    Nishimura, Nobutaka
    Oda, Yuki
    Miyamoto, Tatsuki
    Iida, Kota
    Tomizawa, Mitsuru
    Shimizu, Takuto
    Owari, Takuya
    Ohnishi, Kenta
    Hori, Shunta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Torimoto, Kazumasa
    Fujii, Tomomi
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Health-related quality of life of advanced melanoma survivors treated with CTLA-4 immune checkpoint inhibition: A matched cohort study
    Boekhout, A. H.
    Rogiers, A.
    Jozwiak, K.
    Boers-Sonderen, M. J.
    van den Eertwegh, A. J. M.
    Hospers, G. A.
    de Groot, J. W.
    Aarts, M. J. B.
    Kapiteijn, E.
    Ten Tije, A. J.
    Piersma, D.
    Vreugdenhil, G.
    Van der Veldt, A. A. M.
    Suijkerbuijk, K. P. M.
    Rozeman, E. A.
    Neyns, B.
    Janssen, K. J.
    van de Poll-Franse, L. V.
    Blank, C. U.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
    Luke, Jason John
    Ott, Patrick Alexander
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2457 - 2462
  • [6] Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
    Boekhout, A. H.
    Rogiers, A.
    Jozwiak, K.
    Boers-Sonderen, M. J.
    van den Eertwegh, A. J.
    Hospers, G. A.
    de Groot, J. W. B.
    Aarts, M. J. B.
    Kapiteijn, E.
    ten Tije, A. J.
    Piersma, D.
    Vreugdenhil, G.
    van der Veldt, A. A.
    Suijkerbuijk, K. P. M.
    Rozeman, E. A.
    Neyns, B.
    Janssen, K. J.
    van de Poll-franse, L. V.
    Blank, C. U.
    ACTA ONCOLOGICA, 2021, 60 (01) : 69 - 77
  • [7] Psychosocial outcome and health-related quality of life (HRQoL) in advanced melanoma survivors.
    Rogiers, Anne
    De Cremer, Jennifer
    Ben Salama, Laila
    De Ridder, Mark
    Bernheim, Jan Ouis
    Neyns, Bart
    Theuns, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
  • [8] Assessment of the Prognostic value of PERCIST 1.0 and Simplified PERCIST ("SPERCIST")" FDG PET in Patients with Advanced Melanoma Treated with Immune Check-point Inhibitors
    Lee, Min-Young
    Crandall, John
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [9] An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
    O'Reilly, Aine
    Hughes, Peta
    Mann, Jasmine
    Lai, Zhuangming
    Teh, Jhia Jiat
    Mclean, Emma
    Edmonds, Kim
    Lingard, Karla
    Chauhan, Dharmisha
    Lynch, Joanna
    Au, Lewis
    Ludlow, Aileen
    Pattison, Natalie
    Wiseman, Theresa
    Turajlic, Samra
    Gore, Martin
    Larkin, James
    Husson, Olga
    SUPPORTIVE CARE IN CANCER, 2020, 28 (02) : 561 - 570
  • [10] An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Aine O’Reilly
    Peta Hughes
    Jasmine Mann
    Zhuangming Lai
    Jhia Jiat Teh
    Emma Mclean
    Kim Edmonds
    Karla Lingard
    Dharmisha Chauhan
    Joanna Lynch
    Lewis Au
    Aileen Ludlow
    Natalie Pattison
    Theresa Wiseman
    Samra Turajlic
    Martin Gore
    James Larkin
    Olga Husson
    Supportive Care in Cancer, 2020, 28 : 561 - 570
12345